Pharmaco - Press Releases

Date	Title	Company
22-Jul-2021	Biotech firm that ‘could revolutionise woundcare’ raises £1.8m	NuVision Biotherapies
22-Jul-2021	DRAGONFLY’S GREEN SHOOTS OF GROWTH DOWN UNDER	Dragonfly Biosciences UK
22-Jul-2021	£54m construction project in Loughborough creates flexible facility for a growing CRO	Charnwood Campus
22-Jul-2021	Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform	Coave Therapeutics
22-Jul-2021	Minaris Will Be the Commercial Manufacturer in Europe for Skysona™, bluebird bio’s Gene Therapy for CALD	Minaris Regenerative Medicine GmbH
22-Jul-2021	UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072	Olink Holding AB
22-Jul-2021	OncoArendi licenses Cresset molecule design software to advance the development of new therapeutics	Cresset
22-Jul-2021	Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe	Calliditas Therapeutics
22-Jul-2021	National Institute for Clinical Excellence (NICE) gives green light for pemigatinib (Pemazyre®), the first targeted therapy for those with the ‘Cinderella’ cancer, cholangiocarcinoma	AMMF
22-Jul-2021	Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders	Hemab
22-Jul-2021	Novo Holdings co-leads Hemab’s US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders	Novo Holdings
22-Jul-2021	Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer™ enabled therapeutics	Aptamer Group
22-Jul-2021	Anocca raises $47m in a Series B Financing to advance its industrialised approach to TCR-T cellular immunotherapy	Anocca
22-Jul-2021	Life sciences hiring booms with vacancies for R&D professionals fuelling demand	CEO of APSCo
22-Jul-2021	Dr. David Ruau joins Sensyne Health from Bayer Pharmaceuticals	Sensyne Health
22-Jul-2021	Supporting Indian Biotherapeutic Companies with Antibody Development	Fusion Antibodies plc
22-Jul-2021	Allergan Aesthetics Continues Partnership with Girls Inc. to Empower Confidence in High School-Aged Girls Interested in STEM	Allergan Aesthetics
22-Jul-2021	VERQUVO® (vericiguat) Approved in the European Union	MSD
22-Jul-2021	Institut Laue Langevin publishes new findings on SARS-CoV-2 infection mechanisms	Sciad Newswire
22-Jul-2021	Relief Announces Issuance of Shares from Authorized Capital as Approved by 2021 Annual General Meeting	RELIEF THERAPEUTICS Holdings AG